Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 3
  • Print publication year: 2009
  • Online publication date: May 2010

18 - Cognitive phenomics

Related content

Powered by UNSILO


Acton, G. S. & Zodda, J. J. (2005). Classification of psychopathology – goals and methods in an empirical approach. Theory and Psychology, 15, 373–399.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd edn.) (DSM–III). Washington, DC: APA.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th edn.) (DSM–IV). Washington, DC: APA.
Bearden, C. & Freimer, N. (2006). Endophenotypes for psychiatric disorders: Ready for primetime? Trends in Genetics, 22, 306–313.
Bilder, R. M. (2005). Cognitive phenomics for neuropsychiatric therapeutics. Schizophrenia Bulletin, 31, 318–319.
Bilder, R. M., Volavka, J., Lachman, H. M. & Grace, A. A. (2004). The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology, 29, 1943–1961.
Devlin, B., Daniels, M. & Roeder, K. (1997). The heritability of IQ. Nature, 388, 468–471.
Embretson, S. E. & Reise, S. P. (2002). Item Response Theory for Psychologists. Mahwah, NJ: Lawrence Erlbaum Associates.
Fan, J., Wu, Y., Fossella, J. & Posner, M. (2001). Assessing the heritability of attentional networks. BMC Neuroscience, 2, 14.
Freimer, N. & Sabatti, C. (2003). The human phenome project. Nature Genetics, 34, 15–21.
Glatt, S. J., Faraone, S. V. & Tsuang, M. T. (2003). Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry, 160, 469–476.
Haslam, N. (2003). The dimensional view of personality disorders: a review of the taxometric evidence. Clinical Psychology Review, 23, 75–93.
Haslam, N. & Kim, H. C. (2002). Categories and continua: a review of taxometric research. Genetic Social and General Psychology Monographs, 128, 271–320.
Kendler, K. S. (2005). “A gene for . . .”: the nature of gene action in psychiatric disorders. American Journal of Psychiatry, 162, 1243–1252.
Kessler, R. C., McGonagle, K. A., Zhao, S., et al. (1994). Lifetime and 12-month prevalence of DSM–III–R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
Kupfer, D. J., First, M. B. & Regier, D. A. (2002). A Research Agenda for DSM–V. Washington, DC: American Psychiatric Association.
Murray, C. J. L. & Lopez, A. D. (1996). The Global Burden of Disease and Injury Series, Vol. 1: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press.
Nolan, K. A., Bilder, R. M., Lachman, H. M. & Volavka, J. (2004). Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. American Journal of Psychiatry, 161, 359–361.
Regier, D. A., Narrow, W. E., Rae, D. S. et al. (1993). The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry, 50, 85–94.
Reise, S. P. & Henson, J. M. (2003). A discussion of modern versus traditional psychometrics as applied to personality assessment scales. Journal of Personal Assessment, 81, 93–103.
Shattuck, D. W., Mirza, M., Adisetiyo, V. et al. (2008). Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage, 39, 1064–1080.
Zerhouni, E. (2005). Fiscal Year 2006 Budget Request. House Subcommittee on Labor-HHS-Education Appropriations.